- Trials with a EudraCT protocol (168)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
168 result(s) found for: Palliative surgery.
Displaying page 1 of 9.
EudraCT Number: 2004-004452-39 | Sponsor Protocol Number: PDT-01-2004 | Start Date*: 2005-01-24 |
Sponsor Name:Christel B. Lajer, Dep. of Otolaryngology head and neck surgery, Rigshospitalet | ||
Full Title: Photodynamic therapy as palliative treatment for recurrent squamous cell carcinom of the head and neck region | ||
Medical condition: Recurrent squamous cell carcinoma of the head and neck Region | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000134-22 | Sponsor Protocol Number: MDCO-CAN-15-01 | Start Date*: 2021-01-14 |
Sponsor Name:Chiesi Farmaceutici S.p.A. | ||
Full Title: A Prospective, Open-Label, Single-Arm, Multi-Center Study to Assess The Pharmacokinetics/Pharmacodynamics (PK/PD) AND Safety Of Different Cangrelor Doses In Neonatal Subjects At Risk Of Thrombosis. | ||
Medical condition: Postoperative neonatal cardiac subjects who are undergoing surgery for placement of systemic-to pulmonary artery palliative shunts (e.g., Blalock-Taussig or central shunt), right ventricle to pulmo... | ||
Disease: | ||
Population Age: Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2014-003197-16 | Sponsor Protocol Number: 810_OPBG_2014 | Start Date*: 2014-12-10 |
Sponsor Name:Bambino Gesù Children's Hospital | ||
Full Title: A Phase III randomized, controlled, open-label on the effects of parenteral nutrition early start to the late start in the ICU cardiac surgery | ||
Medical condition: Patients undergoing or awaiting palliative / corrective pediatric cardiac surgery who should receive parenteral nutrition | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: IT (Temporarily Halted) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000074-51 | Sponsor Protocol Number: GBG 39 | Start Date*: 2005-05-03 |
Sponsor Name:GBG Forschungs GmbH | ||
Full Title: A multicenter phase II study to determine the efficacy of capecitabine as first line monochemotherapy in patients with HER2 negative, medium-risk, metastatic breast cancer | ||
Medical condition: patients with HER2 negative metastatic breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000209-22 | Sponsor Protocol Number: 12GA029 | Start Date*: 2013-06-07 | |||||||||||
Sponsor Name:Research and Development Nottingham University Hospital | |||||||||||||
Full Title: A pilot study to assess the efficacy of intravenous iron isomaltoside 1000 (Monofer®) in the management of anaemia associated with the palliative management of upper gastrointestinal adenocarcinoma | |||||||||||||
Medical condition: The medical condition to be investigated is anaemia in patients with oesophageal or gastric cancer planned to undergo palliative chemotherapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004575-21 | Sponsor Protocol Number: UCL-ONCO008-02 | Start Date*: 2008-10-23 |
Sponsor Name:Cliniques Universitaires St Luc | ||
Full Title: A single arm, multicenter, phase II trial of RAD001 as monotherapy in the palliative treatment of patient with locally advanced or metastatic transitional cell carcinoma after failure of platinum-b... | ||
Medical condition: Palliative patients with locally advanced or metastatic transitional cell carcinoma after failure of platinum-based chemotherapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Prematurely Ended) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-001938-42 | Sponsor Protocol Number: UCL-ONCO2011-01 | Start Date*: 2012-01-24 |
Sponsor Name:Cliniques universitaires Saint-Luc | ||
Full Title: Randomized Phase II Study of CABAZITAXEL versus METHOTREXATE in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based therapy | ||
Medical condition: To evaluate the efficacy of cabazitaxel in patients with palliative head and neck previously treated with platinum-based therapy. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002647-29 | Sponsor Protocol Number: ELECTROCHEMO-1 | Start Date*: 2014-02-12 | |||||||||||||||||||||
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | |||||||||||||||||||||||
Full Title: Clinical trial to evaluate the efficacy and tolerability of electrochemotherapy for palliative treatment in patients with head and neck squamous cell carcinoma | |||||||||||||||||||||||
Medical condition: head and neck squamous cell carcinoma | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003965-27 | Sponsor Protocol Number: OCTO-072 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: A phase I dose escalation safety study combining the ATR inhibitor M6620 with chemoradiotherapy in oesophageal cancer & other sold cancers using time to event continual reassessment method | |||||||||||||
Medical condition: Stage A1 and B: Oesophageal carcinoma Stage A2: Any advanced solid tumours (carcinomas) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000290-24 | Sponsor Protocol Number: I3Y-MC-JPCY | Start Date*: 2020-08-17 | ||||||||||||||||
Sponsor Name:Eli Lilly and Company | ||||||||||||||||||
Full Title: CYCLONE 1: A Phase 2 Study of Abemaciclib in Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated with a Novel Hormonal Agent and Taxane-based Chemotherapy | ||||||||||||||||||
Medical condition: Metastatic Castration-Resistant Prostate Cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-006041-36 | Sponsor Protocol Number: PH-L19IL2TNFBASK-04/21 | Start Date*: 2022-02-08 |
Sponsor Name:Philogen S.p.A. | ||
Full Title: A phase II study of L19IL2/L19TNF in patients with skin cancers amenable to intralesional treatment | ||
Medical condition: Patients with malignant tumors of the skin amenable to intratumoral injection, and in a curative or neoadjuvant or palliative intention, including: • Basal cell carcinoma (BCC) • Cutaneous squamou... | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) IT (Trial now transitioned) ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005695-15 | Sponsor Protocol Number: NL56123.031.15 | Start Date*: 2017-07-14 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:NKI-AVL | ||||||||||||||||||||||||||||||||||||||
Full Title: Treatment of PERitoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: the PERISCOPE II study | ||||||||||||||||||||||||||||||||||||||
Medical condition: Gastric cancer with peritoneal carcinomatosis or tumour positive cytology | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) DK (Trial now transitioned) FI (Ongoing) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004373-23 | Sponsor Protocol Number: ROV-BEM-2003-02 | Start Date*: 2007-08-14 | |||||||||||
Sponsor Name:LABORATORIOS FARMACEUTICOS ROVI, S.A. | |||||||||||||
Full Title: MULTICENTRIC, RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND THE SAFETY OF THE PROPHYLAXIS WITH BEMIPARIN 3,500 IU/day FOR 28 DAYS COMPARED TO 8 DAYS, IN V... | |||||||||||||
Medical condition: VENOUS THROMBOEMBOLIC DISEASE IN PATIENTS UNDERGOING ONCOLOGICAL ABDOMINAL OR PELVIC SURGERY | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004123-20 | Sponsor Protocol Number: UCL-ONCO2012-01 | Start Date*: 2013-03-11 |
Sponsor Name:Centre du Cancer, Cliniques universitaires Saint-Luc | ||
Full Title: A single arm, multicenter, phase II study of BEZ235 as monotherapy in patients with locally advanced or metastatic Transitional Cell Carcinoma (TCC) after failure of platinum based chemotherapy. | ||
Medical condition: To treat patients with histollogically- or cytologically-confirmed locally advanced or metastatic TCC not amenable to curative surgery or radiation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-002362-74 | Sponsor Protocol Number: DBG01 | Start Date*: 2014-09-02 | |||||||||||
Sponsor Name:Skåne University Hospital, Department of Oncology | |||||||||||||
Full Title: Palliative short-course hypofractionated radiotherapy followed by chemotherapy in adenocarcinoma of the esophagus or esophogastric junction trial - a phase II clinical trial protocol. | |||||||||||||
Medical condition: Patients with adenocarcinoma of the esophagus or esophagogastric junction. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005816-29 | Sponsor Protocol Number: 2006-002-0201-ONC | Start Date*: 2008-06-17 |
Sponsor Name:Royal Wolverhampton Hospitals Trust | ||
Full Title: A Pilot Study of Taxotere (Docetaxel), Cisplatin and 5FU (TPF) in the Palliative Treatment of Squamous Cell Carcinoma of the Head and Neck | ||
Medical condition: Locally recurrent or metastatic squamous call carcinoma of the head and neck | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-002190-49 | Sponsor Protocol Number: REO 008 | Start Date*: 2006-11-08 | |||||||||||
Sponsor Name:Oncolytics Biotech Inc | |||||||||||||
Full Title: A Multi-Centre Single-Arm Phase II Study To Evaluate The Biological Effects Of Intratumoral Administration of Wild-Type Reovirus (REOLYSIN®) in Combination with Low Dose Radiation in Patients With ... | |||||||||||||
Medical condition: Advanced or metastatic solid tumours that are refractory to standard therapy or for which no standard curative therapy exists | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002349-38 | Sponsor Protocol Number: 2-54-52030-156 | Start Date*: 2007-02-26 |
Sponsor Name:Beaufour Ipsen Pharma-Ipsen Biotech Department | ||
Full Title: Phase III multicentre, Randomised, Double Blind, Comparative study to assess the efficacy and safety of lanreotide 30mg versus placebo as a palliative treatment of clinical symptoms associated with... | ||
Medical condition: Patient having a high digestive obstruction of malignant origin i.e. located on the upper part of the gastro-intestinal tract (stomach, duodenum, small bowel) for whom surgery is inappropriate. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-002721-37 | Sponsor Protocol Number: CLBH589BDE03T | Start Date*: 2009-06-09 |
Sponsor Name:Medizinische Fakultät der TU-München, vertreten durch den Dekan | ||
Full Title: An open-label, uncontrolled phase II trial of HDAC inhibitor LBH589 in patients with chemo-refractory metastatic gastric cancer overexpressing histone deacetylases - CLBH589BDE03T | ||
Medical condition: A study with patients with chemo-refractory metastatic gastric cancer overexpressing histone deacetylases (HDACs) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2004-004340-42 | Sponsor Protocol Number: AS1404-201 | Start Date*: 2005-04-06 |
Sponsor Name:Antisoma Research Ltd | ||
Full Title: An Open Label, Randomized, Phase I/II Study of DMXAA in Combination with Carboplatin and Paclitaxel in Patients with Locally Advanced and Metastatic Non-Small Cell Lung Cancer. | ||
Medical condition: Patients with histologically confirmed locally advanced or metastatic NSCLC (Stage IIIb/IV) without prior chemotherapy will be included. Patients must have at least one unidimensionally measurable... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
